What is Christopher & Dana Reeve Foundation?
Operating at the intersection of cutting-edge biotechnology and social welfare, the Christopher & Dana Reeve Foundation is dedicated to curing spinal cord injury through the systematic financing of global research initiatives. The organization functions as a critical nexus for scientific collaboration, uniting elite researchers to accelerate breakthroughs in neuro-regeneration and restorative medicine. Beyond its research mandate, the foundation manages the National Paralysis Resource Center, a vital infrastructure that provides comprehensive support, referral services, and educational resources to over 100,000 individuals. With a rigorous adherence to the Better Business Bureau's standards for charity accountability, the foundation maintains a high-trust profile, effectively translating philanthropic investment into measurable improvements in quality of life and independence for those impacted by paralysis.
The foundation's market position is unique, as it operates not merely as a grant-making entity but as a strategic partner in the healthcare ecosystem. By maintaining a cooperative agreement with the Administration for Community Living, the organization ensures that its advocacy efforts are deeply integrated with public policy, thereby amplifying the voices of the community it serves while driving systemic change in disability support services.
How much funding has Christopher & Dana Reeve Foundation raised?
Christopher & Dana Reeve Foundation has raised a total of $390K across 2 funding rounds:
Debt
$350K
Debt
$40K
Debt (2020): $350K with participation from PPP
Debt (2021): $40K led by PPP
Key Investors in Christopher & Dana Reeve Foundation
PPP
Public-Private Partnership
What's next for Christopher & Dana Reeve Foundation?
With the recent influx of capital, the Christopher & Dana Reeve Foundation is poised to scale its research portfolio and expand the reach of its resource centers. The strategic roadmap focuses on deepening investments in high-potential labs that are currently navigating the complexities of clinical trials. By prioritizing translational research, the foundation aims to shorten the timeline from bench-side discovery to patient-side application. Furthermore, the organization is expected to enhance its digital infrastructure to better serve a growing global demographic, ensuring that the latest advancements in paralysis care are accessible to all. This phase of growth reflects a mature, late-stage operational strategy designed to maximize impact while maintaining the highest standards of fiscal transparency and organizational integrity.
See full Christopher & Dana Reeve Foundation company page
